type here...

CATEGORIES

Press Release

LATEST

1...101112Page 11 of 12

TRENDING

EDITORS CHOICE

FREOPP Study: How New York’s Single Payer Health Care Bill Affects the Working Poor

Medika Life -
The flawed design of the New York Health Act would be felt most acutely by low-income New Yorkers, a new FREOPP study finds. This Single-Payer Health

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

NLR. Millions at Risk from Leprosy. Study Reveals Figures

Medika Life -
To interrupt leprosy transmission and reduce annual new cases significantly, preventive treatment needs to be implemented in all leprosy-endemic countries

Are You Feeding Your Prostate Cancer?

Medika Life -
Men with prostate cancer need the right diet and a consistent exercise routine to help them manage their weight. Studies show that overweight men often have worse prostate cancer outcomes

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories